$Exela Technologies (XELA.US)$
IRVING, Texas, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Exela Technologies, Inc. ("Exela" or the "Company") (NASDAQ: XELA) announced today that it has amended the previously announced offer (the "Offer") to exchange up to 100,000,000 shares of its Common Stock for unsecured 6.00% senior notes due 2029 (the "New Notes"). The Offer has been amended to replace the New Notes with perpetual, convertible preferred stock with a 6% annual dividend (the "Preferred Stock"),...
IRVING, Texas, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Exela Technologies, Inc. ("Exela" or the "Company") (NASDAQ: XELA) announced today that it has amended the previously announced offer (the "Offer") to exchange up to 100,000,000 shares of its Common Stock for unsecured 6.00% senior notes due 2029 (the "New Notes"). The Offer has been amended to replace the New Notes with perpetual, convertible preferred stock with a 6% annual dividend (the "Preferred Stock"),...
3
$Novavax (NVAX.US)$
going FDA approval in September only
going FDA approval in September only
2